Introduction Sarcopenia is a muscle disease that is associated with a decline in muscle
strength and function. When this condition coexists with sarcopenia, it is characterized as …

Background & aims Sarcopenic obesity (SO) is defined by a relatively low muscle mass in
combination with obesity. Sarcopenic obesity was first noted as a health risk in geriatric …

Objectives Recently metabolic aspects linked to sarcopenic obesity (SO) were investigated.
Extant studies involved especially older people from Asian or White-mixed American …

Background & aims Ageing brings alterations in body composition, as skeletal muscle
gradually declines and accumulation of adipose tissue accompanies it. Although sarcopenia …

Aim Our study aimed to identify Skeletal Muscle Mass Index (SMMI) cut-off values for
sarcopenia diagnosis in our population and determine the prevalance of sarcopenia, and to …

Objectives Sarcopenic obesity has not yet been widely defined. The aim of this study was to
evaluate the prevalence of sarcopenia in a group of severely obese adults from southern …

Sarcopenic obesity is associated with several negative health outcomes. However, the
prevalence of this condition–and the relationship to physical performance parameters …

Background & aims There have been several attempts to come up with a global operational
definition of sarcopenia (S), and consequently, a definition of S has been established, to …

Background Sarcopenia is a progressive age‐related skeletal muscle disorder associated
with increased likelihood of adverse outcomes. Muscle wasting is often accompanied by an …

Background Sarcopenic obesity (SO) is associated with poorer physical performance in the
elderly and will increase in relevance with population ageing and the obesity epidemic. The …